Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 9699-9715
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9699
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9699
Figure 12 Adsorption dependent release of interleukin-1 receptor antagonist, and hepatocyte growth factor from myeloid lineage leucocytes (granulocytes and monocytes) in in-vitro setting.
Hepatocyte growth factor (HGF) is known to promote ulcer healing and cell regeneration, while interleukin-1 receptor antagonist (IL-1ra) is strongly anti-inflammatory[113]. GMA: Granulocyte and monocyte apheresis.
- Citation: Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715
- URL: https://www.wjgnet.com/1007-9327/full/v20/i29/9699.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.9699